{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:52:24Z","timestamp":1788306744191,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Epidemiological studies on primary biliary cholangitis (PBC) have been based primarily on tertiary referral case series. We aimed to estimate the incidence and prevalence and describe comorbidities in hospitalized patients with PBC in Italy using a national hospital\u2010based data source. Data were extracted from the National Hospital Discharge Database, which includes all Italian individuals discharged from any hospital in the country. All adults diagnosed with biliary cirrhosis (International Classification of Diseases, Ninth Revision, Clinical Modification, 571.6) as the primary or secondary diagnosis from 2011 to 2015 were included. To determine whether a comorbidity was either more or less frequent in PBC patients compared with the general hospitalized Italian population, the standardized hospitalization ratio (SHR) was calculated. A total of 5,533 incident cases were identified from 2011 to 2015, 3,790 of whom were females (68.5%; female to male [F:M] ratio, 2.2:1). Prevalent cases were 9,664, of whom 7,209 were females (74.6%; F:M ratio, 2.9:1). The incident rate was 1.03\u00a0\u00d7\u00a0100,000 in males and 1.92\u00a0\u00d7\u00a0100,000 in females; prevalence was 1.89\u00a0\u00d7\u00a0100,000 in males and 4.75\u00a0\u00d7\u00a0100,000 in females. Extrahepatic autoimmune diseases, malignant neoplasms of liver and intrahepatic biliary ducts, and malignant neoplasms of gallbladder and extrahepatic bile ducts were found more frequently in PBC patients than in the general hospitalized population (SHR\u00a0&gt;\u00a0100), whereas cerebrovascular diseases and ischemic heart diseases were less frequent in PBC individuals (SHR\u00a0&lt;\u00a0100). <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> This national study provides a survey of comorbidities associated with PBC. Hospitalized patients with PBC are more likely to have extrahepatic autoimmune diseases, hepatocellular carcinoma, and biliary tract cancers and a low risk of cardiovascular events.<\/jats:p>","DOI":"10.1002\/hep4.1407","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T11:39:49Z","timestamp":1563190789000},"page":"1250-1257","source":"Crossref","is-referenced-by-count":15,"title":["A National Hospital\u2010Based Study of Hospitalized Patients With Primary Biliary Cholangitis"],"prefix":"10.1097","volume":"3","author":[{"given":"Valerio","family":"Manno","sequence":"first","affiliation":[{"name":"Service of Statistics,National Institute of Health,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gerussi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery,University of Milano\u2010Bicocca,Monza,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery,University of Milano\u2010Bicocca,Monza,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Minelli","sequence":"additional","affiliation":[{"name":"Service of Statistics,National Institute of Health,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Taruscio","sequence":"additional","affiliation":[{"name":"National Center for Rare Diseases,National Institute of Health,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Conti","sequence":"additional","affiliation":[{"name":"Service of Statistics,National Institute of Health,Rome,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-1998","authenticated-orcid":false,"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery,University of Milano\u2010Bicocca,Monza,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"hep41407-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"hep41407-bib-0002-20240114","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep41407-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hidden gems of the epidemiology of primary biliary cirrhosis","volume":"46","year":"2013","journal-title":"J Autoimmun"},{"key":"hep41407-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0b013e32834ff314","article-title":"Describing the epidemiology of rheumatic diseases: methodological aspects","volume":"24","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"hep41407-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population\u2010based study","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep41407-bib-0006-20240114","first-page":"1","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"hep41407-bib-0007-20240114","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2018.11.008","article-title":"Epidemiology of primary biliary cholangitis in Italy: evidence from a real\u2010world database","volume":"51","year":"2019","journal-title":"Dig Liver Dis"},{"key":"hep41407-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow\u2010up study from Sweden","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"hep41407-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","article-title":"Primary biliary cirrhosis: an epidemiological study","volume":"281","year":"1980","journal-title":"Br Med J"},{"key":"hep41407-bib-0010-20240114","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in healthy adults","volume":"27","year":"1998","journal-title":"Hepatology"},{"key":"hep41407-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"hep41407-bib-0012-20240114","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/lt.21172","article-title":"Modified Charlson Comorbidity Index for predicting survival after liver transplantation","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"hep41407-bib-0013-20240114","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2017.12.019","article-title":"Impact of comorbidities on patient outcomes after interferon\u2010free therapy\u2010induced viral eradication in hepatitis","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep41407-bib-0014-20240114","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre\u2010therapeutic classification of co\u2010morbidity in chronic disease","volume":"23","year":"1970","journal-title":"J Chronic Dis"},{"key":"hep41407-bib-0015-20240114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"hep41407-bib-0016-20240114","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"hep41407-bib-0017-20240114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"hep41407-bib-0018-20240114","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK\u2010PBC risk scores: derivation and validation of a scoring system for long\u2010term prediction of end\u2010stage liver disease in primary biliary cholangitis","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"hep41407-bib-0019-20240114","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"hep41407-bib-0020-20240114","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.301.5630.163","article-title":"Epidemiology. The epidemiologist\u2019s dream: Denmark","volume":"301","year":"2003","journal-title":"Science"},{"key":"hep41407-bib-0021-20240114","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","article-title":"The epidemiology and natural history of primary biliary cirrhosis","volume":"24","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep41407-bib-0022-20240114","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep41407-bib-0023-20240114","first-page":"167","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"145","year":"2017","journal-title":"J Hepatol"},{"key":"hep41407-bib-0024-20240114","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview\u2010based study of 1032 patients","volume":"42","year":"2005","journal-title":"Hepatology"},{"key":"hep41407-bib-0025-20240114","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","year":"2006","journal-title":"Gut"},{"key":"hep41407-bib-0026-20240114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","year":"2016","journal-title":"Gut"},{"key":"hep41407-bib-0027-20240114","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population\u2010based case\u2010control study","volume":"5","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep41407-bib-0028-20240114","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1023\/A:1018831903371","article-title":"Case report: primary biliary cirrhosis associated with cholangiocarcinoma","volume":"43","year":"1998","journal-title":"Dig Dis Sci"},{"key":"hep41407-bib-0029-20240114","first-page":"285","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","year":"2002","journal-title":"Gut"},{"key":"hep41407-bib-0030-20240114","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","article-title":"Lipoprotein\u2010X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation","volume":"45","year":"2004","journal-title":"J Lipid Res"},{"key":"hep41407-bib-0031-20240114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0895-4356(02)00531-0","article-title":"Long\u2010term survival and cause\u2010specific mortality in patients with cirrhosis of the liver","volume":"56","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"hep41407-bib-0032-20240114","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365529709025067","article-title":"Primary biliary cirrhosis in the Netherlands: an analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures","volume":"32","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"hep41407-bib-0033-20240114","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","article-title":"Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?","volume":"15","year":"1992","journal-title":"Hepatology"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.1407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.1407","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:07:20Z","timestamp":1705248440000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1407","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}